Treatment success rate and time to culture conversion under a prospective BPaL cohort study
IJTLD Open · 2025-05 · 2 (5) · 284-290
DOI: 10.5588/ijtldopen.24.0524 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift IJTLD Open, online erschienen am 01.05.2025. Verfasst von E Burhan und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND In July 2022, Indonesia implemented the 6-month BPaL (bedaquiline, pretomanid, linezolid) regimen under operational research (OR) for selected drug-resistant tuberculosis patients. The study aimed to assess treatment success rate (TSR) and time to sputum culture conversion (TSCC). METHODS A prospective cohort study in fifteen sites between July 2022 and March 2023 enrolled patients with rifampicin-resistant/multidrug-resistant TB with additional fluoroquinolone resistance or intolerance/failures of previous second-line TB treatment. TSR was descriptively analysed, and Kaplan-Meier and Cox proportional-hazards analyses were used to evaluate TSCC. RESULTS A total of 87 patients were enrolled, 3 were withdrawn, and 84 completed treatment and had outcomes; 82 (97.6%) patients had successful treatment, 1 (1.2%) died, and 1 (1.2%) had failure. Overall, 61 (72.6%) patients had positive cultures at baseline, and favourable outcomes were included in the TSCC analysis; all 61 (100%) converted within the first 3 months (median 32 days of treatment, IQR 30.0–56.0). None of the six variables were statistically associated with conversion time. CONCLUSION The Indonesian BPaL OR showed a highly promising TSR of 97.6%, with 100% sputum conversion within 3 months. The lack of observed statistical differences in the TSCC across variables shows that the BPaL treatment will be equally effective in all patient groups.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
- Persahabatan Hospital, Jakarta, Indonesia.
- Yayasan KNCV Indonesia, Jakarta, Indonesia.
- National Tuberculosis Programme, Ministry of Health of the Republic of Indonesia, Jakarta, Indonesia.
- Directorate of Mental Health, Ministry of Health of the Republic of Indonesia, Jakarta, Indonesia.
- Division of TB Elimination and Health Systems Innovations, KNCV Tuberculosis Foundation, The Hague, The Netherlands.
Zitieren
APA
Burhan, E., Sugiharto, J., Soemarno, M., Juan, A., Runtu, Y., Yuvensia, A., Ramadhani, R., Sabono, J., Lailiyah, A., Fenni, F., Farikha, M., Pakasi, T., Pambudi, I., Mbenga, M., Koppelaar, I., Mirtskhulava, V., Wares, F., Jerene, D., Jung, J. K., …, & Gebhard, A. (2025). Treatment success rate and time to culture conversion under a prospective BPaL cohort study. IJTLD Open, 2(5), 284-290. https://doi.org/10.5588/ijtldopen.24.0524
Vancouver
Burhan E, Sugiharto J, Soemarno M, Juan A, Runtu Y, Yuvensia A, et al. Treatment success rate and time to culture conversion under a prospective BPaL cohort study. IJTLD Open. 2025;2(5):284-290. doi:10.5588/ijtldopen.24.0524
BibTeX
@article{Burhan2025,
author = {Burhan, E and Sugiharto, J and Soemarno, M and Juan, A and Runtu, Y and Yuvensia, A and Ramadhani, R and Sabono, J and Lailiyah, A and Fenni, F and Farikha, M and Pakasi, T and Pambudi, I and Mbenga, M and Koppelaar, I and Mirtskhulava, V and Wares, F and Jerene, D and Jung, J K and Lee, J S and Foraida, S and Juneja, S and Diachenko, M and Gebhard, A},
title = {Treatment success rate and time to culture conversion under a prospective BPaL cohort study},
journal = {IJTLD Open},
year = {2025},
volume = {2},
number = {5},
pages = {284--290},
doi = {10.5588/ijtldopen.24.0524}
}
EUVIMED